CD8A and colonic neoplasm: In a mouse model of colon cancer with human PD-1 and PD-L1, WCC administration reduced tumor growth by approximately 70% and elevated intra-tumoral CD8+ T cells, IL-2, and GrB (Figure 5 and Figure 6).